Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Headache rates in SURPASS trials Across the SURPASS clinical trials, between 4% and 14% of participants reported headaches depending on the dose they received
The greatest absolute risk reduction comes from improving very elevated glycaemic levels, and a more modest reduction results from near normalisation of plasma glucose levels [2, 14]
Many people have had good experiences, but there are also some complaints, especially about slow shipping and customer service
Larger clinical studies will be required to determine whether these improvements lead to higher pregnancy rates, better birth outcomes and long-term reproductive benefits
US$ 23.64
US$ 29.11
US$ 25.82
US$ 20.04
US$ 29.25
US$ 23.99
